Free Trial

Minerva Neurosciences (NERV) SEC Filings & 10K Form

Minerva Neurosciences logo
$2.18 -0.05 (-2.24%)
As of 04:00 PM Eastern

Recent Minerva Neurosciences SEC Filings

DateFilerForm TypeView
01/13/2025
7:46 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
4:45 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
HASLER HANS PETER (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Kupfer David (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Laghrissi-Thode Fouzia (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Minerva Neurosciences (Issuer)
VAN HEEK G JAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:21 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
6:09 AM
Minerva Neurosciences (Filer)
Form DEFA14A
10/22/2024
6:12 AM
Minerva Neurosciences (Filer)
Form ARS
10/22/2024
6:06 AM
Minerva Neurosciences (Filer)
Form DEF 14A
10/11/2024
3:10 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2024
4:07 PM
Minerva Neurosciences (Filer)
Form 10-K/A
02/27/2024
7:04 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
5:30 AM
Minerva Neurosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
Minerva Neurosciences (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NERV) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners